A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).
Sakashita H, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita T, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y.
Sakashita H, et al. Among authors: suhara k.
Thorac Cancer. 2022 May;13(9):1267-1275. doi: 10.1111/1759-7714.14376. Epub 2022 Mar 23.
Thorac Cancer. 2022.
PMID: 35322551
Free PMC article.
Clinical Trial.